[Prevalence of HTLV-I/II infection among blood donors in Santa Fe Province, Argentina]. 2004

Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
Laboratorio Central, Red de Laboratorios del Programa Provincial, Santa Fe, Argentina.

Subsequent to the National Epidemiologic Surveillance Program developed in 1997 by the National AIDS Program, anti-HTLV-I/II antibodies among blood donors in Santa Fe Province started to be detected. On the basis of this initial finding, it was regarded of interest to evaluate the true HTLV-I/II seroprevalence in this population during a four-year survey. Thus, from 1997 up to 2002, 9425 samples were studied from 17 out of the 19 provincial departments. Out of the total sampling, 38 proved reactive by agglutination techniques, 18 of which were confirmed by western blot (WB). Out of the latter, 10 were HTLV-I/II seropositive with a final prevalence of 0.1% (10/9425), whereas 7 were indeterminate and 1 negative. Among these 10 confirmed sera, 2 (0.02%) were HTLV, 3 (0.03%) HTLV-I and 5 (0.05%) HTLV-II. It should be highlighted that the presence of HTLV-I/II infection in blood donors in Santa Fe Province was demonstrated for the first time, with a prevalence greater than that reported for blood donors in non-endemic Argentine areas. Such findings confirm the need of corresponding systematic screening through regulatory blood bank norms in Santa Fe Province.

UI MeSH Term Description Entries
D008403 Mass Screening Organized periodic procedures performed on large groups of people for the purpose of detecting disease. Screening,Mass Screenings,Screening, Mass,Screenings,Screenings, Mass
D001782 Blood Donors Individuals supplying blood or blood components for transfer to histocompatible recipients. Blood Donor,Donor, Blood,Donors, Blood
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001118 Argentina Country located in southern South America, bordering the South Atlantic Ocean, between Chile and Uruguay.
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective
D015490 HTLV-I Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 1. Human T-lymphotropic Virus 1 Infection,Human T-lymphotropic Virus 1 Infections,Infections, HTLV-I,HTLV I Infections,HTLV-I Infection,Human T lymphotropic Virus 1 Infection,Human T lymphotropic Virus 1 Infections,Infection, HTLV-I,Infections, HTLV I
D015491 HTLV-II Infections Diseases caused by HUMAN T-LYMPHOTROPIC VIRUS 2. Human T-lymphotropic Virus 2 Infection,Human T-lymphotropic Virus 2 Infections,Infections, HTLV-II,HTLV-II Infection,Human T lymphotropic Virus 2 Infection,Human T lymphotropic Virus 2 Infections,Infection, HTLV-II,Infections, HTLV II
D015995 Prevalence The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time. Period Prevalence,Point Prevalence,Period Prevalences,Point Prevalences,Prevalence, Period,Prevalence, Point,Prevalences
D016036 Seroepidemiologic Studies EPIDEMIOLOGIC STUDIES based on the detection through serological testing of characteristic change in the serum level of specific ANTIBODIES. Latent subclinical infections and carrier states can thus be detected in addition to clinically overt cases. Seroprevalence,Seroepidemiologic Study,Seroepidemiological Study,Studies, Seroepidemiologic,Study, Seroepidemiologic,Seroepidemiological Studies,Seroprevalences,Studies, Seroepidemiological,Study, Seroepidemiological

Related Publications

Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
December 1992, Journal of acquired immune deficiency syndromes,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
June 2020, Multiple sclerosis and related disorders,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
January 2005, AIDS research and human retroviruses,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
January 1994, Vox sanguinis,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
June 1991, Lancet (London, England),
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
January 2002, Revista Argentina de microbiologia,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
January 1982, Revista Argentina de microbiologia,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
October 1992, Microbiologica,
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
January 2001, Internal medicine (Tokyo, Japan),
Roque O Brun, and Laura Astarloa, and Horacio E Salomon, and Mirna M Biglione
January 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association,
Copied contents to your clipboard!